Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Athena Diagnostics offers new genetic tests to aid in the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy, and certain movement disorders. The lab-developed tests are available through Athena, a business of Quest Diagnostics.
Illumina’s TruSight Tumor, for NGS-based somatic variant detection in solid tumors, provides optimized amplicon-based library preparation of 26 oncogenes and tumor suppressor genes selected for their involvement in common solid tumors, including lung, colon, melanoma, gastric, and ovarian cancer.
Bio SB, through its partnership with ZytoVision of Germany, can now distribute a complete line of CE-approved chromogenic in situ hybridization and fluorescent in situ hybridization probes targeted for use in lung carcinomas. The line of lung carcinoma CISH and FISH probes includes ZytoLight ALK/EML4 Tricheck triple-color probe (Z-2144-200), ZytoDot EGFR/CEN7 dual-color probe (C-3033-400), and many more.
Biotix’s Tip Eject is a pipette tip reloading system that allows users to reload to Biotix racks without transfer devices. The packaging is translucent, which allows for easy tip identification while fully protecting tips from contamination due to contact and environmental particulates. Tip Eject cards are made from 100 percent recycled polypropylene, which helps labs reduce waste without sacrificing the quality of pipette tips.
Thermo Fisher Scientific’s Dionex UltiMate 3000 biocompatible rapid separation liquid chromatography system is designed to combine ultrahigh-performance liquid chromatography with the corrosion-resistant flow path required to analyze proteins, peptides, nucleic acids, and biotherapeutics.
NorDx, a member of MaineHealth, is the nation’s first clinical laboratory to acquire Sysmex America’s XN series automated hematology analyzers. The Sysmex XN-3000 configuration enables enhanced diagnostic capabilities and greater efficiency, which transforms NorDx into an accountable care laboratory model and shepherds in a new era of performance standards for quality care in New England, according to Stan Schofield, president of NorDx and senior VP of MaineHealth.
Tanner Scientific’s TN1500 tissue-embedding center is a user-friendly workstation that was designed with the input of hundreds of histology lab supervisors. The workstation features a four-line digital display for easy programming (all surface temperatures can be viewed and adjusted without the need to scroll), a fully adjustable cryoplate that can be placed on the right or left side, an adjustable-intensity bright LED light on a flexible tube, a 2.6-gallon tank capacity, an extra-large magnifying glass on a flexible tube, and more.
Medical’s highly specific p40 mouse monoclonal anti-p40 [BC28] demonstrated similar sensitivity and specificity to the company’s rabbit polyclonal p40, staining 97 percent (65/67) of cases of lung squamous cell carcinoma and zero percent (0/71) cases of lung adenocarcinoma, in an in-house study. In addition, the antibody has significantly less background and does not stain macrophages.
MolecularMD Corp. has entered into a license agreement to obtain rights to commercialize patent-pending intellectual property pertaining to use of LKB1 for diagnostic, prognostic, and predictive uses in humans in non-small cell lung cancer.
The African Society of Laboratory Medicine, working in conjunction with the CDC, Clinton Health Access Initiative, UNAIDS, and WHO/AFRO, has partnered with SoftTech Health in a program to network the laboratories continentwide with the LabQMS (Quality Management Software).
